Valproic acid-associated acute liver failure in children: Case report and analysis of liver transplantation outcomes in the United States

Journal of Pediatrics

Volumn 158, Issue 5, 2011, Pages 802-807

  Mindikoglu, Ayse L ^a   King, Dale ^b   Magder, Laurence S ^a   Ozolek, John A ^b   Mazariegos, George V ^b   Shneider, Benjamin L ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; OXCARBAZEPINE; VALPROIC ACID;

ACUTE LIVER FAILURE; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHILD; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MALE; UNITED STATES; VALPROIC ACID;

EID: 79954418396     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.10.033     Document Type: Article

References (40)

1. A.E. Bryant III, and F.E. Dreifuss Valproic acid hepatic fatalities. III. US experience since 1986 Neurology 46 1996 465 469 (Pubitemid 26081333)
2. F.E. Dreifuss, and D.H. Langer Hepatic considerations in the use of antiepileptic drugs Epilepsia 28 Suppl. 2 1987 S23 S29
3. F.E. Dreifuss, N. Santilli, D.H. Langer, K.P. Sweeney, K.A. Moline, and K.B. Menander Valproic acid hepatic fatalities: a retrospective review Neurology 37 1987 379 385 (Pubitemid 17031731)
4. A.L. Mindikoglu, L.S. Magder, and A. Regev Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database Liver Transpl 15 2009 719 729
5. B. Fromenty, and D. Pessayre Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity Pharmacol Ther 67 1995 101 154
6. S. Krahenbuhl, S. Brandner, S. Kleinle, S. Liechti, and D. Straumann Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure Liver 20 2000 346 348 (Pubitemid 30488006)
7. S. Ponchaut, F. van Hoof, and K. Veitch In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Relevance of CoA sequestration to the observed inhibitions Biochem Pharmacol 43 1992 2435 2442
8. S. Ponchaut, and K. Veitch Valproate and mitochondria Biochem Pharmacol 46 1993 199 204 (Pubitemid 23218602)
9. F.G. Debray, M. Lambert, and G.A. Mitchell Disorders of mitochondrial function Curr Opin Pediatr 20 2008 471 482
10. M.F. Silva, C.C. Aires, P.B. Luis, J.P. Ruiter, L. Ijlst, and M. Duran Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review J Inherit Metab Dis 2008
11. A. Delarue, O. Paut, J.M. Guys, M.F. Montfort, V. Lethel, and B. Roquelaure Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure Pediatr Transplant 4 2000 67 71 (Pubitemid 30064645)
12. N. Kayihan, I. Nennesmo, B.G. Ericzon, and A. Nemeth Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage Pediatr Transplant 4 2000 211 214 (Pubitemid 30471311)
13. R. McFarland, G. Hudson, R.W. Taylor, S.H. Green, S. Hodges, and P.J. McKiernan Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1) Arch Dis Child 93 2008 151 153 (Pubitemid 351204758)
14. R.E. Appleton, K. Farrell, D.A. Applegarth, J.E. Dimmick, L.T. Wong, and A.G. Davidson The high incidence of valproate hepatotoxicity in infants may relate to familial metabolic defects Can J Neurol Sci 17 1990 145 148 (Pubitemid 20177528)
15. B.J. Alpers Diffuse progressive degeneration of gray matter of cerebrum Arch Neurol Psychiatr 25 1931 469 505
16. P.R. Huttenlocher, G.B. Solitare, and G. Adams Infantile diffuse cerebral degeneration with hepatic cirrhosis Arch Neurol 33 1976 186 192
17. B. Dubern, P. Broue, C. Dubuisson, V. Cormier-Daire, D. Habes, and C. Chardot Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children Transplantation 71 2001 633 637 (Pubitemid 32268064)
18. M. Thomson, P. McKiernan, J. Buckels, D. Mayer, and D. Kelly Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood J Pediatr Gastroenterol Nutr 26 1998 478 481 (Pubitemid 28160703)
19. W.S. Lee, and R.J. Sokol Mitochondrial hepatopathies: advances in genetics and pathogenesis Hepatology 45 2007 1555 1565 (Pubitemid 46918340)
20. E.M. Sokal, R. Sokol, V. Cormier, F. Lacaille, P. McKiernan, and F.J. Van Spronsen Liver transplantation in mitochondrial respiratory chain disorders Eur J Pediatr 158 Suppl. 2 1999 S81 S84
21. S.S. Rabinowitz, D. Gelfond, C.K. Chen, E.S. Gloster, P.F. Whitington, and S. Sacconi Hepatocerebral mitochondrial DNA depletion syndrome: clinical and morphologic features of a nuclear gene mutation J Pediatr Gastroenterol Nutr 38 2004 216 220
22. SAS Institute. SAS, V9.2. Cary, NC. Available at http://www.sas.com/.
23. Minitab 15 Statistical Software (2007). (Computer software]. State College PM. Available at: www.minitab.com.
24. M.W. Russo, J.A. Galanko, R. Shrestha, M.W. Fried, and P. Watkins Liver transplantation for acute liver failure from drug induced liver injury in the United States Liver Transpl 10 2004 1018 1023 (Pubitemid 39232756)
25. J. Parra, J. Iriarte, and S.J. Pierre-Louis Valproate toxicity Neurology 47 1996 1608
26. S.A. Konig, H. Siemes, F. Blaker, E. Boenigk, G. Gross-Selbeck, and F. Hanefeld Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities Epilepsia 35 1994 1005 1015 (Pubitemid 24346307)
27. J.Y. Raskind, and G.M. El-Chaar The role of carnitine supplementation during valproic acid therapy Ann Pharmacother 34 2000 630 638 (Pubitemid 30257492)
28. H. Siemes, H. Nau, K. Schultze, W. Wittfoht, E. Drews, and J. Penzien Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity Epilepsia 34 1993 332 346 (Pubitemid 23106762)
29. D.L. Coulter Carnitine, valproate, and toxicity J Child Neurol 6 1991 7 14
30. S. Russell Carnitine as an antidote for acute valproate toxicity in children Curr Opin Pediatr 19 2007 206 210 (Pubitemid 46668075)
31. M.D. Sztajnkrycer Valproic acid toxicity: overview and management J Toxicol Clin Toxicol 40 2002 789 801 (Pubitemid 35423414)
32. M.A. Thomson, S. Lynch, R. Strong, R.W. Shepherd, and W. Marsh Orthotopic liver transplantation with poor neurologic outcome in valproate-associated liver failure: a need for critical risk-benefit appraisal in the use of valproate Transplant Proc 32 2000 200 203 (Pubitemid 30100811)
33. K. Murayama, and A. Ohtake Children's toxicology from bench to bed - liver injury (4): mitochondrial respiratory chain disorder and liver disease in children J Toxicol Sci 34 Suppl. 2 2009 SP237 SP243
34. R.K. Naviaux, and K.V. Nguyen POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion Ann Neurol 55 2004 706 712 (Pubitemid 38544331)
35. K.V. Nguyen, E. Ostergaard, S.H. Ravn, T. Balslev, E.R. Danielsen, A. Vardag, and P.J. McKiernan POLG mutations in Alpers syndrome Neurology 65 2005 1493 1495 (Pubitemid 41552791)
36. K.V. Nguyen, F.S. Sharief, S.S. Chan, W.C. Copeland, and R.K. Naviaux Molecular diagnosis of Alpers syndrome J Hepatol 45 2006 108 116 (Pubitemid 44183678)
37. R. Horvath, G. Hudson, G. Ferrari, N. Futterer, S. Ahola, E. Lamantea, and H. Prokisch Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene Brain 129 2006 1674 1684 (Pubitemid 43999402)
38. J.D. Stewart, R. Horvath, E. Baruffini, I. Ferrero, S. Bulst, P. Watkins, R.J. Fontana, C.P. Day, and P.F. Chinnery POLG determines the risk of sodium valproate induced liver toxicity Hepatology 2010 In press
39. P.E. Lheureux, A. Penaloza, S. Zahir, and M. Gris Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Crit Care 9 2005 431 440 (Pubitemid 41498538)
40. P.E. Lheureux, and P. Hantson Carnitine in the treatment of valproic acid-induced toxicity Clin Toxicol (Phila) 47 2009 101 111